SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-22-000200
Filing Date
2022-02-11
Accepted
2022-02-11 16:23:36
Documents
2
Group Members
ORBIMED ASIA GP III, L.P.ORBIMED CAPITAL LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ss792150_sc13g.htm SC 13G 70571
2 JOINT FILING AGREEMENT ss792150_ex99a.htm EX-99.A 9167
  Complete submission text file 0000947871-22-000200.txt   81340
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13G

Mailing Address BUILDING 3, 418 GUILIN ROAD XUHUI DISTRICT SHANGHAI F4 200030
Business Address BUILDING 3, 418 GUILIN ROAD XUHUI DISTRICT SHANGHAI F4 200030 00862164031522
Gracell Biotechnologies Inc. (Subject) CIK: 0001826492 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91967 | Film No.: 22621423
SIC: 2834 Pharmaceutical Preparations